TNGX logo

Tango Therapeutics (TNGX) Company Overview

Profile

Full Name:

Tango Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 3, 2020

Indexes:

Not included

Description:

Tango Therapeutics (TNGX) is a biotechnology company focused on developing innovative cancer therapies. They use advanced technology to discover and create treatments that target specific cancer cells, aiming to improve patient outcomes and personalize cancer care. Their goal is to make cancer treatment more effective and tailored to individual needs.

Events Calendar

Earnings

Next earnings date:

Mar 18, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 5, 24 Cantor Fitzgerald
Overweight
Nov 11, 24 B. Riley Securities
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Nov 7, 24 Guggenheim
Buy
Oct 28, 24 HC Wainwright & Co.
Buy
Sep 10, 24 HC Wainwright & Co.
Buy
Aug 8, 24 Wedbush
Outperform
Jul 17, 24 Jefferies
Buy
Jul 9, 24 HC Wainwright & Co.
Buy
Jul 9, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Tango Therapeutics?
  • Does Tango Therapeutics pay dividends?
  • What sector is Tango Therapeutics in?
  • What industry is Tango Therapeutics in?
  • What country is Tango Therapeutics based in?
  • When did Tango Therapeutics go public?
  • Is Tango Therapeutics in the S&P 500?
  • Is Tango Therapeutics in the NASDAQ 100?
  • Is Tango Therapeutics in the Dow Jones?
  • When was Tango Therapeutics's last earnings report?
  • When does Tango Therapeutics report earnings?
  • Should I buy Tango Therapeutics stock now?

What is the ticker symbol for Tango Therapeutics?

The ticker symbol for Tango Therapeutics is NASDAQ:TNGX

Does Tango Therapeutics pay dividends?

No, Tango Therapeutics does not pay dividends

What sector is Tango Therapeutics in?

Tango Therapeutics is in the Healthcare sector

What industry is Tango Therapeutics in?

Tango Therapeutics is in the Biotechnology industry

What country is Tango Therapeutics based in?

Tango Therapeutics is headquartered in United States

When did Tango Therapeutics go public?

Tango Therapeutics's initial public offering (IPO) was on September 3, 2020

Is Tango Therapeutics in the S&P 500?

No, Tango Therapeutics is not included in the S&P 500 index

Is Tango Therapeutics in the NASDAQ 100?

No, Tango Therapeutics is not included in the NASDAQ 100 index

Is Tango Therapeutics in the Dow Jones?

No, Tango Therapeutics is not included in the Dow Jones index

When was Tango Therapeutics's last earnings report?

Tango Therapeutics's most recent earnings report was on Nov 6, 2024

When does Tango Therapeutics report earnings?

The next expected earnings date for Tango Therapeutics is Mar 18, 2025

Should I buy Tango Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions